loader
Please Wait
Applying Filters...

Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X

End Use API - CAS 79617-89-3 manufacturers and suppliers on PharmaCompass

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Zeon Pharma Industries India Pvt Ltd (3)

02 Shamrock Medicaments (1)

79617-89-3
Zeon Pharma Industries India Pvt ltd is an ISO & GMP certified manufacturer & exporter of Bulk drugs / Se...
Zeon Pharma Industries India Pvt ltd is an ISO & GMP certified manufacturer & exporter of Bulk drugs / Semi finish formulations & Intermediate and also has a GMP certified Manufacturing facility for Phytochemicals / Herbal extract and Enzymes through our associates.
Zeon Pharma Industries India Pvt Ltd Company Banner

WBC 2024

Not Confirmed

envelop Contact Supplier
79617-89-3
Zeon Pharma Industries India Pvt ltd is an ISO & GMP certified manufacturer & exporter of Bulk drugs / Se...
Zeon Pharma Industries India Pvt ltd is an ISO & GMP certified manufacturer & exporter of Bulk drugs / Semi finish formulations & Intermediate and also has a GMP certified Manufacturing facility for Phytochemicals / Herbal extract and Enzymes through our associates.
Zeon Pharma Industries India Pvt Ltd Company Banner

WBC 2024

Not Confirmed

envelop Contact Supplier
79617-89-3
Zeon Pharma Industries India Pvt ltd is an ISO & GMP certified manufacturer & exporter of Bulk drugs / Se...
Zeon Pharma Industries India Pvt ltd is an ISO & GMP certified manufacturer & exporter of Bulk drugs / Semi finish formulations & Intermediate and also has a GMP certified Manufacturing facility for Phytochemicals / Herbal extract and Enzymes through our associates.
Zeon Pharma Industries India Pvt Ltd Company Banner

WBC 2024

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
79617-89-3
Shamrock Medicaments Ltd, formerly known as Doctor Lifeline Remedies India Ltd, has an intriguing evoluti...
Shamrock Medicaments Ltd, formerly known as Doctor Lifeline Remedies India Ltd, has an intriguing evolution. Established within the robust Shamrock Group in 2001 with a hefty $35 million investment, its inception aimed to cater to the global pharmaceutical market by leveraging India's capabilities. Over time, the company diversified its offerings, expanding into custom manufacturing of pharmaceutical raw materials, intermediates, and chemicals pertinent to the pharmaceutical industry. This strategic expansion likely enabled Shamrock Medicaments Ltd to cement its position as a significant player in the pharmaceutical landscape.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY